Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to evaluate the efficacy and non-inferiority of a
lipid-lowering medication regimen comprised of the medications ezetimibe and fenofibrate
taken daily, versus atorvastatin daily in lowering levels of low-density lipoprotein (LDL-C)
cholesterol. Additionally, other aims would include effects on other types of blood
cholesterol and examining the safety of the ezetimibe and fenofibrate regimen, as compared to
atorvastatin.